Related Experiment Video

Updated: Jun 18, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Interaction map and selection of microRNA targets in Parkinson's disease-related genes

Shinde Santosh P1, Neelima Arora, Pranjal Sarma

  • 1Functional Genomics and Gene Silencing Group, Centre for Cellular and Molecular Biology, Hyderabad 500007, AP, India.

Journal of Biomedicine & Biotechnology
|November 14, 2009
PubMed

Insights

Researchers investigated microRNA gene regulation in Parkinson's disease (PD). They identified potential microRNA targets in PD-related genes, offering new avenues for therapeutic applications and diagnosis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Parkinson's disease (PD) is a complex, multigenic neurodegenerative disorder primarily affecting the elderly.
  • MicroRNAs (miRNAs) are small noncoding RNAs that play crucial roles in gene regulation.
  • Understanding miRNA-mediated gene regulation in PD is essential for developing novel therapeutic strategies.

Purpose of the Study:

  • To predict and analyze microRNA target sites on genes associated with Parkinson's disease.
  • To elucidate the mode of microRNA action and identify "hot spots" of miRNA regulation in PD genes.
  • To explore the convergence of predicted miRNA target sites using multiple algorithms for enhanced accuracy.

Main Methods:

  • Utilized miRanda (version 1.0b) to predict human miRNA target sites on 29 selected PD-related genes.
  • Employed TargetScan (version 5.1) for comparative analysis of miRNA target sites in the 3' untranslated region (3'UTR).
  • Analyzed the location and properties of miRNA target sites, including multiplicity and cooperativity, for 112 midbrain-expressed miRNAs.

Main Results:

  • miRanda analysis elucidated miRNA action modes based on target site locations within Parkinson's genes.
  • Identified "hot spots" representing sites prone to regulation by multiple miRNAs.
  • Convergence of miRanda and TargetScan predictions revealed 48 target sites for midbrain-specific miRNAs in 9 genes.

Conclusions:

  • The study identified potential microRNA candidates for Parkinson's disease-related genes.
  • The findings provide a foundation for developing targeted miRNA-based diagnostics and therapeutics for PD.
  • This research highlights the complex interplay between miRNAs and their targets in the context of Parkinson's disease.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...